Equity · Healthcare
DARE
NASDAQDaré Bioscience (DARE)
The line runs 1.44 USD on 12 August through 0.6751 USD on 9 November, on a scale from 0.5 to 2.0. Days the market did not trade hold the previous close, flat.
- Market cap
- 10.3M USD
- Revenue, year to Dec 2025
- 1.0M USD
- EPS, diluted, year to Dec 2025
- −1.20 USD
- Avg volume
- 3.6K
- Mentions, 30 days
- 2
as of Nov 9, 2026
Have Daré Bioscience (DARE) insiders bought or sold shares recently?
DARE's newest Form 4 filing is dated 30 June 2026: none in the last 90 days.
| Reported | Insider | Type | Shares | Value |
|---|---|---|---|---|
| 30 Jun 2026 | Steele Robin JoanDirector | Award | 26,540 | |
| 30 Jun 2026 | RASTETTER WILLIAM HDirector | Award | 38,862 | |
| 30 Jun 2026 | Matz Gregory WDirector | Award | 30,805 | |
| 30 Jun 2026 | Kelley Susan L.Director | Award | 23,696 | |
| 30 Jun 2026 | Grossman Jessica D.Director | Award | 26,066 |
Which funds hold Daré Bioscience (DARE)?
0 of the 45 institutional funds we track reported a Daré Bioscience position for the quarter ended 30 Jun 2026; the latest of those filings landed 14 Aug 2026.
| Fund | Position | Shares | Value | Shares q/q |
|---|---|---|---|---|
| Renaissance Technologies | Exited | |||
| Two Sigma Investments | Exited |
What has been filed or recorded for Daré Bioscience (DARE)?
The filings we hold for Daré Bioscience, newest first: 6 fails-to-deliver days, 6 quarterly earnings reports, 2 annual reports and 5 reported financial figures, the latest dated 13 Oct 2026. No next earnings date is announced in SEC filings yet.
| And | ||||
|---|---|---|---|---|
| 13 Oct 2026 | Fails to deliver | Shares failed to deliver | 1,460 shares | 1K USD notional · 0.010% of shares out |
| 07 Oct 2026 | Fails to deliver | Shares failed to deliver | 23,963 shares | 20K USD notional · 0.157% of shares out |
| 06 Oct 2026 | Fails to deliver | Shares failed to deliver | 31,680 shares | 27K USD notional · 0.207% of shares out |
| 05 Oct 2026 | Fails to deliver | Shares failed to deliver | 31,715 shares | 27K USD notional · 0.207% of shares out |
| 30 Sep 2026 | Fails to deliver | Shares failed to deliver | 10,688 shares | 9K USD notional · 0.070% of shares out |
| 28 Sep 2026 | Fails to deliver | Shares failed to deliver | 15,816 shares | 12K USD notional · 0.103% of shares out |
| 30 Jun 2026 | Quarterly earnings | Q2 2026 reported | EPS −0.20 USD | |
| 30 Jun 2026 | Financials | Total assets | 22.4M USD | at period end |
| 30 Jun 2026 | Financials | Total equity | −560K USD | at period end |
| 31 Mar 2026 | Quarterly earnings | Q1 2026 reported | EPS −0.21 USD | |
| 31 Dec 2025 | Annual report | FY 2025 reported | EPS −1.20 USD | |
| 31 Dec 2025 | Financials | Revenue | 1.0M USD | fiscal year |
| 31 Dec 2025 | Financials | Net income | −13.4M USD | fiscal year |
| 31 Dec 2025 | Financials | Diluted EPS | −1.20 USD | fiscal year |
| 30 Sep 2025 | Quarterly earnings | Q3 2025 reported | EPS −0.28 USD | |
| 30 Jun 2025 | Quarterly earnings | Q2 2025 reported | EPS −0.45 USD | |
| 31 Mar 2025 | Quarterly earnings | Q1 2025 reported | EPS −0.50 USD | |
| 31 Dec 2024 | Annual report | FY 2024 reported | EPS −0.48 USD | |
| 30 Sep 2024 | Quarterly earnings | Q3 2024 reported | EPS −0.55 USD | Revenue $0M |
What is Reddit saying about Daré Bioscience (DARE)?
Reddit mentioned DARE 2 times in the 30 days to 10 November 2026, across 2 of the communities we track. All of them were scored for sentiment: 100% read bullish, 0% bearish and 0% neither. Reddit data updated 10 November 2026.
30-day window, Method
How do Reddit mentions of Daré Bioscience (DARE) compare with its price?
Share ↗
Which subreddits are talking about Daré Bioscience (DARE)?
30 days
| Community | Share | Mentions | Net sentiment |
|---|---|---|---|
| r/commodities | 60% | 3 | −0.02 |
| r/wallstreetbets | 40% | 2 | +0.18 |
What do people ask about Daré Bioscience (DARE)?
What did Daré Bioscience shares close at?0.6751
Daré Bioscience closed at 0.6751 USD on 9 Nov 2026, up 9.54% on the close before. That is the end-of-day price from Finazon, not a live quote.
What is Daré Bioscience’s market cap?10.3M
Daré Bioscience is worth 10.3M USD by market value as of 9 Nov 2026, which is the share price times the shares on issue from its SEC filings.
What is Daré Bioscience’s revenue?1.0M
Daré Bioscience reported revenue of 1.0M USD for the year ended 31 Dec 2025, as filed with the SEC. See Filings
Have Daré Bioscience insiders bought or sold shares recently?
No Daré Bioscience insider has filed a Form 4 in the last 90 days; the most recent filing we hold is dated 30 Jun 2026 (SEC Form 4). See Insiders
Which funds own Daré Bioscience?0 of 45
0 of the 45 funds we track reported a Daré Bioscience position for the quarter ended 30 Jun 2026, per their SEC Form 13F filings. The largest reported positions were Renaissance Technologies and Two Sigma Investments. See Funds
When did Daré Bioscience last report earnings?−0.20
Daré Bioscience last reported earnings on 30 Jun 2026 for Q2 2026, with EPS of −0.20 USD; no next date is announced in SEC filings yet. See Filings
What is Reddit saying about Daré Bioscience?0 mentions
Daré Bioscience was mentioned 0 times in the last 7 days across the finance subreddits we track, and 2 times over the trailing 30 days. Of the 2 mentions scored for sentiment, 100% read bullish and 0% bearish. That is a social signal, not investment advice. See Reddit
Answers are generated from the live figures on this page — Reddit crowd data, SEC filings and open company records — and update as the data does.
References
- Finazonprior-day close, indicative (IEX-derived, not the official close)
- TradingViewthe price chart widget, drawn by TradingView from their own data
- RedditReddit ingest across the tracked finance subreddits
- SEC EDGARForm 4 filings (insider transactions)
- SEC EDGAR13F filings
- SECSEC fails-to-deliver (CNS) data
- SEC EDGARXBRL company facts, latest period ended 30 Jun 2026
- SEC EDGARreported earnings figures and scheduled report dates
- SEC EDGARValuation computed from SEC EDGAR filings